Free Trial

Apogee Therapeutics (APGE) Insider Trading & Ownership

Apogee Therapeutics logo
$83.91 -0.03 (-0.04%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$84.43 +0.52 (+0.62%)
As of 04:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Apogee Therapeutics (NASDAQ:APGE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$150.84M
Get APGE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Apogee Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APGE Insider Buying and Selling by Quarter

Apogee Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/6/2026Sell5,500$84.14$462,770.00  
4/8/2026Sell20,000$82.58$1,651,600.00  
4/1/2026Sell5,500$84.84$466,620.00  
3/11/2026Sell20,000$74.78$1,495,600.00  
3/4/2026Sell5,500$71.06$390,830.00  
2/11/2026Sell20,000$63.35$1,267,000.00  
2/4/2026Sell5,500$65.79$361,845.00  
1/22/2026
Fairmount Funds Management Llc
Director
Sell1,750,000$76.30$133,525,000.00  
1/14/2026Sell20,000$81.11$1,622,200.00  
1/7/2026Sell18,700$77.84$1,455,608.00  
Millionaire warns: Move your money before May 15 (Ad)

Larry Benedict - the trader who generated $274 million in client profits and beat the S&P 500 by 18 times in 2025 - says Trump's installation of a new Federal Reserve chair is triggering the most significant shift in U.S. markets in nearly 20 years. When the Fed cut rates in 2020, his readers had a chance at 62% gains. A 2022 rate-hike signal produced 117% in under a month. Now Benedict has identified the single ticker he believes will be at the center of the coming money flows - and he's revealing it free before May 15.tc pixel

Click here to see the one ticker Larry Benedict is recommending now
12/10/2025Sell20,000$75.38$1,507,600.00  
12/4/2025Sell10,900$75.00$817,500.00  
12/4/2025Sell40,000$75.01$3,000,400.00  
11/13/2025Sell20,000$63.01$1,260,200.00  
11/5/2025Sell10,785$55.07$593,929.95  
10/1/2025Sell5,110$39.80$203,378.00  
9/3/2025Sell2,725$37.87$103,195.75  
8/6/2025Sell2,725$37.78$102,950.50  
7/2/2025Sell10,090$45.09$454,958.10  
6/4/2025Sell2,725$36.96$100,716.00  
(Data available from 1/1/2013 forward)

APGE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Apogee Therapeutics includes Carl Dambkowski, Fairmount Funds Management Llc, Jane Henderson, Mark C Mckenna, Michael Thomas Henderson, and Nimish P Shah. Learn more on insiders at APGE.

24.30% of Apogee Therapeutics stock is owned by insiders. Learn more on APGE's insider holdings.

The following insider purchased APGE shares in the last 24 months: Mark C Mckenna ($990,800.00).

Insiders have purchased a total of 20,000 APGE shares in the last 24 months for a total of $990,800.00 bought.

The following insiders have sold APGE shares in the last 24 months: Carl Dambkowski ($8,273,119.65), Fairmount Funds Management Llc ($133,525,000.00), Jane Henderson ($289,560.00), and Michael Thomas Henderson ($21,372,250.00).

Insiders have sold a total of 2,267,070 Apogee Therapeutics shares in the last 24 months for a total of $163,459,929.65 sold.



This page (NASDAQ:APGE) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners